Abbas Mokhtarieh Amir

Title: Abbas Mokhtarieh Amir: Innovator in Asymmetric Liposome Technology

Introduction

Abbas Mokhtarieh Amir is a prominent inventor based in Daejeon, South Korea. He has made significant contributions to the field of biotechnology, particularly in the development of innovative drug delivery systems. His work focuses on enhancing the efficiency of encapsulating nucleic acids and hydrophilic anionic compounds.

Latest Patents

Abbas Mokhtarieh Amir holds a patent for "Asymmetric liposomes for the highly efficient encapsulation of nucleic acids and hydrophilic anionic compounds, and method for preparing same." This invention relates to asymmetric liposomes designed for high encapsulation efficiency of nucleic acids and hydrophilic anionic compounds. The asymmetric liposomes consist of a cationic lipid with a small head group as the internal lipid and a neutral or PEGylated lipid with a large head group as the external lipid. This innovative design allows for the effective encapsulation of nucleic acids and anionic compounds, making it suitable for applications such as gene therapy and drug delivery.

Career Highlights

Abbas Mokhtarieh Amir is affiliated with the Korea Research Institute of Bioscience and Biotechnology. His research has led to advancements in drug delivery systems, which are crucial for the treatment of various medical conditions. His work is recognized for its potential impact on gene therapy and the delivery of challenging hydrophilic anionic drugs.

Collaborations

Abbas Mokhtarieh Amir has collaborated with notable colleagues, including Myung Kyu Lee and Bong Hyun Chung. These collaborations have contributed to the advancement of research in the field of biotechnology and drug delivery systems.

Conclusion

Abbas Mokhtarieh Amir is a key figure in the development of asymmetric liposome technology, with a focus on enhancing drug delivery systems. His innovative patent reflects his commitment to advancing biotechnology for therapeutic applications.